Literature DB >> 15661832

Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis.

Norikazu Harii1, Christopher J Lewis, Vasilly Vasko, Kelly McCall, Uruguaysito Benavides-Peralta, Xiaolu Sun, Matthew D Ringel, Motoyasu Saji, Cesidio Giuliani, Giorgio Napolitano, Douglas J Goetz, Leonard D Kohn.   

Abstract

Toll-like receptors (TLRs) initiate an innate immune response. TLR3 on dendritic cells recognize double-stranded (ds) RNA and then signal increases in cytokines and recognition molecules important for immune cell interactions. In this report, we demonstrate TLR3 mRNA and protein are expressed on Fisher rat thyroid cell line-5 (FRTL-5) thyroid cells and are functional because incubating cells with polyinosine-polycytidylic acid causes 1) transcriptional activation of both the nuclear factor kappaB (NF-kappaB)/Elk1 and interferon (IFN) regulatory factor-3/IFN-beta signal paths, 2) posttranscriptional activation of NF-kappaB and ERK1/2, and 3) increased IFN-beta mRNA. TLR3 can be overexpressed, along with dsRNA-dependent protein kinase, major histocompatibility complex-I or II, and IFN regulatory factor-1, by transfecting dsRNA into the cells, infection with Influenza A virus, or incubation with IFN-beta, but not by incubation with dsRNA or IFNgamma, or by dsDNA transfection. A methimazole (MMI) derivative, phenylmethimazole, to a significantly greater degree than MMI, prevents overexpression by inhibiting increased transcriptional activation of IRF-3 and of IFN-stimulated response elements, phosphorylation of signal transducers and activation of transcription (STAT-1), but not NF-kappaB activation. TLR3 can be functionally overexpressed in cultured human thyrocytes by dsRNA transfection or IFN-beta treatment. Immunohistochemical studies show that TLR3 protein is overexpressed in human thyrocytes surrounded by immune cells in 100% of patients with Hashimoto's thyroiditis examined, but not in normal or Graves' thyrocytes. We conclude that functional TLR3 are present on thyrocytes; TLR3 downstream signals can be overexpressed by pathogen-related stimuli; overexpression can be reversed by phenylmethimazole to a significantly greater extent than MMI by inhibiting only the IFN regulatory factor-3/IFN-beta/signal transducers and activation of transcription arm of the TLR3 signal system; and TLR3 overexpression can induce an innate immune response in thyrocytes, which may be important in the pathogenesis of Hashimoto's thyroiditis and in the immune cell infiltrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661832     DOI: 10.1210/me.2004-0100

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  31 in total

1.  Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3.

Authors:  Mahboubeh S Noori; Pooja M Bhatt; Maria C Courreges; Davoud Ghazanfari; Chaz Cuckler; Crina M Orac; Mark C McMills; Frank L Schwartz; Sudhir P Deosarkar; Stephen C Bergmeier; Kelly D McCall; Douglas J Goetz
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-25       Impact factor: 4.249

2.  Phenylmethimazole and a thiazole derivative of phenylmethimazole inhibit IL-6 expression by triple negative breast cancer cells.

Authors:  Mahboubeh S Noori; John D O'Brien; Zachary J Champa; Sudhir P Deosarkar; Olivia L Lanier; Chunyan Qi; Monica M Burdick; Frank L Schwartz; Stephen C Bergmeier; Kelly D McCall; Douglas J Goetz
Journal:  Eur J Pharmacol       Date:  2017-03-23       Impact factor: 4.432

3.  Demonstration of innate immune responses in the thyroid gland: potential to sense danger and a possible trigger for autoimmune reactions.

Authors:  Akira Kawashima; Kazuko Yamazaki; Takeshi Hara; Takeshi Akama; Aya Yoshihara; Mariko Sue; Kazunari Tanigawa; Huhehasi Wu; Yuko Ishido; Fumihiko Takeshita; Norihisa Ishii; Kanji Sato; Koichi Suzuki
Journal:  Thyroid       Date:  2013-03-18       Impact factor: 6.568

4.  Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers.

Authors:  Minoru Nakamura; Kenji Funami; Atsumasa Komori; Terufumi Yokoyama; Yoshihiro Aiba; Aiko Araki; Yasushi Takii; Masahiro Ito; Mutsumi Matsuyama; Makiko Koyabu; Kiyoshi Migita; Ken Taniguchi; Hikaru Fujioka; Hiroshi Yatsuhashi; Misako Matsumoto; Hiromi Ishibashi; Tsukasa Seya
Journal:  Hepatol Int       Date:  2008-03-26       Impact factor: 6.047

5.  Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

Authors:  Kelly D McCall; Jean R Thuma; Maria C Courreges; Fabian Benencia; Calvin B L James; Ramiro Malgor; Noriko Kantake; William Mudd; Nathan Denlinger; Bret Nolan; Li Wen; Frank L Schwartz
Journal:  Endocrinology       Date:  2014-11-25       Impact factor: 4.736

Review 6.  The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics.

Authors:  Takahiko Kogai; Gregory A Brent
Journal:  Pharmacol Ther       Date:  2012-06-29       Impact factor: 12.310

7.  NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8.

Authors:  Juan Pablo Nicola; Magalí Nazar; Iván Darío Mascanfroni; Claudia Gabriela Pellizas; Ana María Masini-Repiso
Journal:  Mol Endocrinol       Date:  2010-07-28

8.  Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.

Authors:  Anthony L Schwartz; Ramiro Malgor; Eric Dickerson; Ashani T Weeraratna; Andrzej Slominski; Jacobo Wortsman; Norikazu Harii; Aimee D Kohn; Randall T Moon; Frank L Schwartz; Douglas J Goetz; Leonard D Kohn; Kelly D McCall
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

Review 9.  Intervention on toll-like receptors in pancreatic cancer.

Authors:  Juan Vaz; Roland Andersson
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

10.  Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma.

Authors:  Yasuhiro Nihon-Yanagi; Megumi Wakayama; Naobumi Tochigi; Fumi Saito; Hideaki Ogata; Kazutoshi Shibuya
Journal:  J Thyroid Res       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.